Skip to main content

Day: May 6, 2020

CDW Reports First Quarter 2020 Earnings

Reinforces Power of Business Model and StrategyLINCOLNSHIRE, Ill., May 06, 2020 (GLOBE NEWSWIRE) — CDW Corporation (Nasdaq:CDW), a leading multi-brand technology solutions provider to business, government, education and healthcare customers in the United States, the United Kingdom and Canada, today announced first quarter 2020 results. CDW also announced the approval by its Board of Directors of a quarterly cash dividend to be paid in June 2020.“In the first quarter, we saw that now, more than ever, technology is essential to our customers’ ability to operate. Our strong results are a testament to how we help our customers navigate and be successful in a changing world,” said Christine A. Leahy, chief executive officer, CDW. “Our dedicated coworkers and our broad portfolio of products and services enabled our customers...

Continue reading

ScottsMiracle-Gro Announces Second Quarter Results Driven by Strong Growth in Both Major Reporting Segments

Sales guidance increased for Hawthorne; 2020 adjusted EPS guidance re-affirmedHawthorne sales rise 60% driven by continued demand for indoor growing productsU.S. Consumer sales increase 11% with strong growth in consumer purchasesGAAP EPS: $4.43 versus $7.10; Non-GAAP adjusted EPS of $4.50 versus $3.64MARYSVILLE, Ohio, May 06, 2020 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded consumer lawn and garden as well as indoor and hydroponic growing products, today announced company-wide sales increased 16 percent in its fiscal second quarter driven by strong volume growth in both major business segments.For the quarter ended March 28, 2020, GAAP earnings from continuing operations were $4.43 per share compared with $7.10 per share in the prior year. Prior year GAAP results were driven...

Continue reading

EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments

– Total revenues of $7.5 million and net product revenues of $4.7 million –– Cash conservation and reorganization initiatives coupled with recent financings support cash runway into 2021 under current COVID-19 pandemic assumptions –– GLP toxicology studies initiated for EYP-1901, a six-month sustained release anti-VEGF potential treatment for wet age-related macular degeneration –– Management to host a conference call and webcast today at 8:30 AM ET –WATERTOWN, Mass., May 06, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today reported financial results for the first quarter ended March 31, 2020 and highlighted recent corporate developments.“We are pleased with...

Continue reading

Barrick Makes Solid Start to Year

All amounts expressed in US dollarsTORONTO, May 06, 2020 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) built on the solid foundation it laid last year with a robust first quarter performance from all operations in the face of the challenges presented by the global Covid-19 pandemic.Q1 gold production and costs were consistent with full year guidance; debt net of cash was reduced by a further 17% from the end of Q4 to $1.85 billion with no significant maturities until 2033; operating cash flow increased to $889 million and free cash flow1 to $438 million from Q4; net earnings per share was 22 cents; adjusted net earnings per share2 was 16 cents; and the quarterly dividend of 7 cents per share was maintained.Financial and Operating HighlightsKey Performance IndicatorsSolid start to the year from all operationsGold...

Continue reading

BioCryst Reports First Quarter 2020 Financial Results and Upcoming Key Milestones

—Berotralstat approval/launch timelines in U.S., Japan, EU remain on track——Early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases——Patient dosing underway in galidesivir trial in COVID-19 patients in Brazil—RESEARCH TRIANGLE PARK, N.C., May 06, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the first quarter ended March 31, 2020, and provided a corporate update.“This is a transformational year for BioCryst as we prepare to launch berotralstat in multiple territories to bring our oral, once-daily prophylactic medicine to HAE patients, and begin generating significant revenue,” said Jon Stonehouse, president and chief executive officer of BioCryst.“We are excited to see the clinical response in treatment-naïve PNH patents at the 50 mg and...

Continue reading

Astec Industries Reports First Quarter 2020 Results

First Quarter 2020 Highlights (all comparisons are made to the prior year first quarter):Net Sales decreased 11.3% to $288.8MGross margin of 25.6 % increased 200 bpsEPS of $0.91 compared to $0.63 a year ago; adjusted EPS of $1.00 increased 53.8%; $0.42 benefit to EPS attributed to the CARES ActAdjusted EBITDA of $24.3M decreased 4.7%; adjusted EBITDA margin of 8.4% increased 60 bpsSimplified operations into two business segments: Infrastructure Solutions and Materials SolutionsCHATTANOOGA, Tenn., May 06, 2020 (GLOBE NEWSWIRE) — Astec Industries, Inc. (Nasdaq: ASTE) announced today its financial results for first quarter 2020 ending March 31, 2020.First quarter of 2020 net sales of $288.8 million decreased 11.3% compared to $325.8 million for the first quarter of 2019. Domestic sales of $233.9 million decreased 11.0% from $262.9...

Continue reading

MindMed Announces Increase in Bought Deal Offering to Approximately $11.5 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, May 06, 2020 (GLOBE NEWSWIRE) — Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF) (“MindMed” or the “Company”) is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to purchase 21,699,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $0.53 (the “Issue Price”) for gross proceeds of $11,500,470 (the “Offering”). The Company has agreed to grant the Underwriters an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior...

Continue reading

CDW Declares Quarterly Cash Dividend of $0.38 Per Share

LINCOLNSHIRE, Ill., May 06, 2020 (GLOBE NEWSWIRE) — CDW Corporation (Nasdaq:CDW), a leading multi-brand technology solutions provider to business, government, education and healthcare customers in the United States, the United Kingdom and Canada, today announced that its Board of Directors has declared a quarterly cash dividend of $0.38 per common share to be paid on June 10, 2020 to all stockholders of record as of the close of business on May 25, 2020.  This represents a 28.8 percent increase over last year’s dividend. Future dividends will be subject to Board of Director approval.“We remain confident in our liquidity position and the cash flow generation capability of CDW’s business.  Our quarterly dividend to shareholders continues to be an important part of our capital priorities, along with managing leverage and being thoughtful...

Continue reading

Brookfield Business Partners Reports First Quarter 2020 Results

BROOKFIELD, NEWS, May 06, 2020 (GLOBE NEWSWIRE) — Brookfield Business Partners L.P. (NYSE: BBU) (TSX: BBU.UN) (“Brookfield Business Partners”) announced today financial results for the quarter ended March 31, 2020.“The unprecedented impact of the COVID-19 pandemic has dramatically altered the global economic landscape. In light of this our focus has been on protecting the health and safety of our people and partners around the world, while working closely with our management teams to support our operations and maximize liquidity. We are also cautiously considering new investment opportunities,” said Cyrus Madon, CEO of Brookfield Business Partners. “Although we are planning for a very weak business environment through the rest of the year, BBU has substantial liquidity and businesses that are high-quality providers of essential...

Continue reading

Barrick Declares Quarterly Dividend

TORONTO, May 06, 2020 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) today announced that its Board of Directors has declared a dividend for the first quarter of 2020 of US $0.07 per share, payable on June 15, 2020, to shareholders of record at the close of business on May 29, 2020.1Senior executive vice-president and chief financial officer Graham Shuttleworth said that maintaining the dividend level that was increased three times over the last year reflects Barrick’s continued strong financial performance.“The Board believes that the current dividend level is justified by the group’s profitability, continued reduction in net debt and overall strength of our balance sheet supported by the robust five-year and ten-year plans which we have shared with the market,” said Shuttleworth.Enquiries:President and CEOMark...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.